Iovance Biotherapeutics, Inc. IOVA Gain on termination of lease
Gain on termination of lease at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnTerminationOfLease.
The official record: Iovance Biotherapeutics, Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s gain on termination of lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s gain on termination of lease?
- Iovance Biotherapeutics, Inc. (IOVA) reported gain on termination of lease of $1.39M in Q4 2024.
- What does gain on termination of lease mean?
- Captures the financial impact resulting from the early termination or modification of lease agreements. This includes the difference between the carrying amount of the lease liability and the consideration paid to terminate the contract. It serves as a measure of the company's flexibility in managing its physical footprint and real estate commitments.